These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

26 related articles for article (PubMed ID: 36567441)

  • 1. Schizandrin A enhances the sensitivity of gastric cancer cells to 5-FU by promoting ferroptosis.
    Hu L; Zhang Z; Zhu F; Li X; Zou M; Yang R
    Cytotechnology; 2024 Jun; 76(3):329-340. PubMed ID: 38736724
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Randomized controlled trial of intravenous sedation vs general anesthesia for esophageal dilation with percutaneous endoscopic gastrostomy in esophageal cancer patients.
    Sunpaweravong S; Benjhawaleemas P; Karnjanawanichkul O; Yolsuriyanwong K; Ruangsin S; Laohawiriyakamol S; Chaipetch O
    Surg Endosc; 2023 Jul; 37(7):5109-5113. PubMed ID: 36928761
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Randomized phase II study of second-line chemotherapy with the best available 5-fluorouracil regimen versus weekly administration of paclitaxel in far advanced gastric cancer with severe peritoneal metastases refractory to 5-fluorouracil-containing regimens (JCOG0407).
    Nishina T; Boku N; Gotoh M; Shimada Y; Hamamoto Y; Yasui H; Yamaguchi K; Kawai H; Nakayama N; Amagai K; Mizusawa J; Nakamura K; Shirao K; Ohtsu A;
    Gastric Cancer; 2016 Jul; 19(3):902-10. PubMed ID: 26386560
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bolus and infusional 5-fluorouracil combined with cisplatin in advanced gastric cancer.
    Barone C; Cassano A; Landriscina M; Longo R; Astone A; Pozzo C
    Oncol Rep; 2000; 7(6):1305-9. PubMed ID: 11032934
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A pilot study of oxaliplatin, fluorouracil and folinic acid (FOLFOX-6) as first-line chemotherapy in advanced or recurrent gastric cancer.
    Luo HY; Xu RH; Zhang L; Li YH; Shi YX; Lin TY; Han B; Wang F; Qiu MZ; He YJ; Guan ZZ
    Chemotherapy; 2008; 54(3):228-35. PubMed ID: 18560231
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Preliminary report of semimonthly 5-fluorouracil/leucovorin combined with paclitaxel in treatment of advanced gastric cancer (AGC)].
    Zhou NN; Zhou ZM; Liu MZ; Li YH; Xu RH; Teng XY; Xiang XJ; Tian WH; Liu DG; Hu PL; Zhang B; Qiu HJ; Qian SY; He YJ
    Ai Zheng; 2003 Aug; 22(8):867-9. PubMed ID: 12917037
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Correlative analysis between serum dihydropyrimidine dehydrogenase, activity, concentration of 5-fluorouracil and adverse events in the treatment of advanced gastric cancer patients].
    Peng RJ; Dong QM; Shi YX; Cao Y; Zhou ZM; Yuan ZY; Li S; Li H; Jiang WQ
    Ai Zheng; 2006 Aug; 25(8):1039-43. PubMed ID: 16965690
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A Pilot Study of Peritumor Administration of 5-FU for Preventing Bleeding in Advanced Gastric Cancer.
    Kim NH; Park JH; Koo DH; Jung YS; Yang JY; Lee HY
    Korean J Gastroenterol; 2022 Dec; 80(6):273-280. PubMed ID: 36567441
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chemotherapy for advanced gastric cancer.
    Wagner AD; Syn NL; Moehler M; Grothe W; Yong WP; Tai BC; Ho J; Unverzagt S
    Cochrane Database Syst Rev; 2017 Aug; 8(8):CD004064. PubMed ID: 28850174
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Capecitabine for the treatment of advanced gastric cancer.
    Norman G; Soares M; Peura P; Rice S; Suh D; Wright K; Sculpher M; Eastwood A
    Health Technol Assess; 2010 Oct; 14(Suppl. 2):11-7. PubMed ID: 21047486
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Capecitabine for the treatment for advanced gastric cancer: efficacy, safety and ethnicity.
    Ma Y; Tang L; Wang HX; Xu YC; Ma Y; Zhang FC
    J Clin Pharm Ther; 2012 Jun; 37(3):266-75. PubMed ID: 21950464
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The efficacy and toxicity of paclitaxel plus S-1 compared with paclitaxel plus 5-FU for advanced gastric cancer: a PRISMA systematic review and meta-analysis of randomized controlled trials.
    Liu H; Chen X; Sun J; Gao P; Song Y; Zhang N; Lu X; Xu H; Wang Z
    Medicine (Baltimore); 2014 Nov; 93(25):e164. PubMed ID: 25437030
    [TBL] [Abstract][Full Text] [Related]  

  • 13.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 14.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.